Literature DB >> 32162150

Approach to a Child with Congestive Heart Failure.

Manojkumar Rohit1, Sudhansu Budakoty2.   

Abstract

Pediatric heart failure (PHF) is an important cause of mortality and morbidity. Whereas ischemic heart disease is the most important cause of heart failure in adults, congenital heart diseases (CHD) and cardiomyopathies are important etiologies of PHF. Management of PHF also differs from that of adults. Here authors have reviewed the literature on PHF with respect to etiology, symptoms, investigations and treatment strategies.

Entities:  

Keywords:  Cardiomyopathy; Congenital heart diseases (CHD); Heart failure (HF); Pediatric

Mesh:

Year:  2020        PMID: 32162150     DOI: 10.1007/s12098-020-03255-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  47 in total

1.  Congenital heart disease and cardiac surgery in childhood: effects on cognitive function and academic ability.

Authors:  J Wray; T Sensky
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.

Authors:  Jack F Price; Anne K Thomas; Michelle Grenier; Benjamin W Eidem; E O'Brian Smith; Susan W Denfield; Jeffrey A Towbin; William J Dreyer
Journal:  Circulation       Date:  2006-08-28       Impact factor: 29.690

Review 3.  ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.

Authors:  Andrew E Epstein; John P Dimarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Heart Rhythm       Date:  2008-05-19       Impact factor: 6.343

4.  Sustained effects of cardiac rehabilitation in children with serious congenital heart disease.

Authors:  Jonathan Rhodes; Tracy J Curran; Laurel Camil; Nicole Rabideau; David R Fulton; Naomi S Gauthier; Kimberlee Gauvreau; Kathy J Jenkins
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

5.  Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.

Authors:  Charlene M T Robertson; Juzer M Tyebkhan; Abraham Peliowski; Philip C Etches; Po-Yin Cheung
Journal:  Acta Paediatr       Date:  2006-02       Impact factor: 2.299

Review 6.  Clinical value of NT-ProBNP and BNP in pediatric cardiology.

Authors:  Amiram Nir; Nadera Nasser
Journal:  J Card Fail       Date:  2005-06       Impact factor: 5.712

7.  Preliminary single center North American experience with the Berlin Heart pediatric EXCOR device.

Authors:  Stephanie R Rockett; Janet C Bryant; W Robert Morrow; Elizabeth A Frazier; William P Fiser; Wesley A McKamie; Charles E Johnson; Carl W Chipman; Michiaki Imamura; Robert D B Jaquiss
Journal:  ASAIO J       Date:  2008 Sep-Oct       Impact factor: 2.872

8.  Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.

Authors:  Paul Khairy; Susan M Fernandes; John E Mayer; John K Triedman; Edward P Walsh; James E Lock; Michael J Landzberg
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

9.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

Review 10.  Stem cells in pediatric heart failure.

Authors:  F Pillekamp; M Khalil; M Emmel; K Brockmeier; J Hescheler
Journal:  Minerva Cardioangiol       Date:  2008-06       Impact factor: 1.347

View more
  1 in total

1.  Pediatric Cardiology: Updates for Pediatrician.

Authors:  M Zulfikar Ahamed; Manojkumar Rohit
Journal:  Indian J Pediatr       Date:  2020-03-13       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.